White House Budget Includes Ambitious Push to Eliminate Hepatitis C

Matthew Akiyama, M.D., comments on the White House plan to eliminate hepatitis C, noting that more resources are needed for testing and treating people who are in jail or prison and carry the virus. Dr. Akiyama is associate professor of medicine at Einstein and an internist at Montefiore.


Matthew Akiyama, MD, Receives Avenir Grant for Efforts to Hinder HIV/HCV Transmission in Kenya

Matthew Akiyama, M.D., describes his National Institutes of Health award to use new sequencing technology to understand HIV and hepatitis C transmission, which may lead to new prevention and treatment strategies for the diseases. Dr. Akiyama is associate professor of medicine at Einstein and an internist at Montefiore.


Pandemic Inspires New Push to Shrink Jails and Prisons

Matthew Akiyama, M.D., says accelerated decarceration due to the COVID-19 pandemic may have led to less rigorous discharge planning for people in jails and prisons who already have difficulty accessing medical care, treatment for addiction, and other services to help them re-enter society. Dr. Akiyama is assistant professor of medicine at Einstein and an internist at Montefiore.